Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Glycolysis is an ancient metabolic activity. It consists of a set of reactions that convert glucose into energy. This central ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

For decades, scientists assumed that neural stem cells (NSCs) only occur in the brain and spinal cord. A new international ...

The studies also ‘offer hope’ that transplanted cells could tackle symptoms of the condition, such as tremors.

Researchers at Karolinska Institutet have developed a method that shows how the nervous system and sensory organs are formed in an embryo. By labeling stem cells with a genetic "barcode," they have ...

Furthermore, many peripheral neural stem cells that migrate out of the neural tube can differentiate into mature neurons and, to a limited extent, glial cells during embryonic and postnatal ...

known as human-induced pluripotent stem cells, are typically adult skin or blood cells that have been reprogrammed in a lab to become like embryonic stem cells, which are found in early embryos.

Organoids are made to model human organs and are promising for research and therapy, but there are limitations in their growth and function. A recent study found that placenta-derived IL1 under ...